AIM Research is proud to announce the launch of its latest analytical endeavor, the PeMa Quadrant for Commercial Analytics Tools in the Pharmaceutical Industry, February 2024 edition. This innovative framework is designed to serve as an industry benchmark, providing a nuanced evaluation of data vendor capabilities across the spectrum. The AIM Penetration and Maturity (PeMa) Quadrant uniquely combines two critical dimensions: Penetration, measuring the extent of market adoption and reach, and Maturity, assessing the depth of experience, breadth of service offerings, and technological advancement. This dual-axis evaluation not only underscores each company's distinctive approach to delivering world-class services but also neatly categorizes them into four distinct segments: Leaders, Seasoned
AIM Research’s PeMa Quadrant Unveils Leaders in Pharma Analytics Tools
- By 理想
- Published on
Explore the cutting-edge of pharmaceutical analytics with AIM Research's PeMa Quadrant, spotlighting the industry's top vendors in market penetration and maturity.
